Compare $AKTX vs $CNSY | Chartloom

Compare

$AKTX vs $CNSY

Akari Therapeutics PLC · Plus Therapeutics Inc

AKTX

Akari Therapeutics PLC

CNSY

Plus Therapeutics Inc

Compare $AKTX vs $CNSY

Comparing Akari Therapeutics PLC and Plus Therapeutics Inc

AKTXAkari Therapeutics PLC

CNSYPlus Therapeutics Inc

AKTXAkari Therapeutics PLC

Market cap

$17M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-24.4%

52W performance

-78.5%

FCF yield

-63.0%

CNSYPlus Therapeutics Inc

Market cap

$13M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.12x

Rev growth (TTM)

—

YTD performance

-45.2%

52W performance

-45.2%

FCF yield

-267.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AKTX

CNSY

Detailed metrics comparison

AKTX

Akari Therapeutics PLC

CNSY

Plus Therapeutics Inc

Market Cap

AKTX$17M

CNSY$13M

Enterprise Value

AKTX$10M

CNSY$11M

Price

AKTX$8.77

CNSY$1.93

P/E Ratio

AKTXN/A

CNSYN/A

P/S Ratio

AKTX0.00x

CNSY3.16x

EV/Sales

AKTX0.00x

CNSY2.60x

EV/EBITDA

AKTX0.00x

CNSY0.00x

P/B Ratio

AKTX0.83x

CNSY2.22x

P/FCF Ratio

AKTXN/A

CNSYN/A

EV/FCF

AKTX-0.94x

CNSY-0.31x

PEG Ratio

AKTXN/A

CNSYN/A

Forward P/E (NTM)

AKTXN/A

CNSYN/A

Forward P/S (NTM)

AKTXN/A

CNSY1.12x

Revenue (TTM)

AKTX$0

CNSY$4M

Revenue Growth (YoY)

AKTXN/A

CNSYN/A

Forward Rev Growth

AKTX137.9%

CNSY216.6%

Gross Margin (TTM)

AKTX0.0%

CNSY0.0%

Operating Margin (TTM)

AKTX0.0%

CNSY0.0%

EBITDA Margin (TTM)

AKTX0.0%

CNSY-612.0%

Net Margin (TTM)

AKTX0.0%

CNSY-620.7%

FCF Margin (TTM)

AKTXN/A

CNSY-845.3%

Net Income (TTM)

AKTX$-31M

CNSY$-26M

FCF (TTM)

AKTX$-11M

CNSY$-36M

EPS (TTM)

AKTX-$0.40

CNSY-$3.78

ROE (TTM)

AKTX-14745.0%

CNSY-39417.0%

ROA (TTM)

AKTX-7470.0%

CNSY-15136.0%

ROIC (TTM)

AKTX-14027.0%

CNSY-37414.0%

Cash

AKTX$8M

CNSY$2M

Debt

AKTX$693K

CNSY$0

Net Cash/Debt

AKTX$7M

CNSY$2M

Current Ratio (TTM)

AKTX0.60x

CNSY1.37x

Quick Ratio (TTM)

AKTX0.56x

CNSY1.26x

Debt/Equity (TTM)

AKTX0.04x

CNSY0.19x

Debt/Assets (TTM)

AKTX0.0%

CNSY0.0%

Interest Coverage (TTM)

AKTXN/A

CNSYN/A

Net Debt/EBITDA (TTM)

AKTX0.00x

CNSY0.00x

Beta

AKTX1.48

CNSY2.21

52W Performance

AKTX-78.5%

CNSY-45.2%

YTD Performance

AKTX-24.4%

CNSY-45.2%

% from 52W High

AKTX-79.5%

CNSY-53.6%

% from 52W Low

AKTX190.4%

CNSY30.0%

Asset Turnover (TTM)

AKTX0.00x

CNSY0.24x

FCF Yield (TTM)

AKTX-63.0%

CNSY-267.6%

Earnings Yield (TTM)

AKTX-181.3%

CNSY-196.5%

Dividend Yield (TTM)

AKTXN/A

CNSYN/A

Rule of 40

AKTX0.0

CNSY-845.3

EV/GP/RG

AKTXN/A

CNSYN/A

Ticker research

View AKTX research View CNSY research

Metric	AKTX Akari Therapeutics PLC	CNSY Plus Therapeutics Inc
Market & Valuation
Market Cap	$17M	$13M
Enterprise Value	$10M	$11M
Price	$8.77	$1.93
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3.16x
EV/Sales	0.00x	2.60x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.83x	2.22x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.94x	-0.31x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	1.12x
Revenue & Growth
Revenue (TTM)	$0	$4M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	137.9%	216.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-612.0%
Net Margin (TTM)	0.0%	-620.7%
FCF Margin (TTM)	N/A	-845.3%
Net Income (TTM)	$-31M	$-26M
FCF (TTM)	$-11M	$-36M
EPS (TTM)	-$0.40	-$3.78
ROE (TTM)	-14745.0%	-39417.0%
ROA (TTM)	-7470.0%	-15136.0%
ROIC (TTM)	-14027.0%	-37414.0%
Financial Health
Cash	$8M	$2M
Debt	$693K	$0
Net Cash/Debt	$7M	$2M
Current Ratio (TTM)	0.60x	1.37x
Quick Ratio (TTM)	0.56x	1.26x
Debt/Equity (TTM)	0.04x	0.19x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.48	2.21
52W Performance	-78.5%	-45.2%
YTD Performance	-24.4%	-45.2%
% from 52W High	-79.5%	-53.6%
% from 52W Low	190.4%	30.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.24x
FCF Yield (TTM)	-63.0%	-267.6%
Earnings Yield (TTM)	-181.3%	-196.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-845.3
EV/GP/RG	N/A	N/A
Ticker research	View AKTX research	View CNSY research

Valuation

P/S Ratio

AKTX

0.00x

CNSY

3.16x

EV/FCF

AKTX

-0.94x

CNSY

-0.31x

Growth & revenue

Forward Revenue Growth

CNSY

216.6%

AKTX

137.9%

Profitability & performance

Gross Margin

AKTX

0.0%

CNSY

0.0%

ROE

AKTX

-14745.0%

CNSY

-39417.0%

FCF Yield %

AKTX

-63.0%

CNSY

-267.6%

52-Week Performance

CNSY

-45.2%

AKTX

-78.5%

Detailed metrics comparison

AKTX

Akari Therapeutics PLC

CNSY

Plus Therapeutics Inc

Market Cap

AKTX$17M

CNSY$13M

Enterprise Value

AKTX$10M

CNSY$11M

Price

AKTX$8.77

CNSY$1.93

P/E Ratio

AKTXN/A

CNSYN/A

P/S Ratio

AKTX0.00x

CNSY3.16x

EV/Sales

AKTX0.00x

CNSY2.60x

EV/EBITDA

AKTX0.00x

CNSY0.00x

P/B Ratio

AKTX0.83x

CNSY2.22x

P/FCF Ratio

AKTXN/A

CNSYN/A

EV/FCF

AKTX-0.94x

CNSY-0.31x

PEG Ratio

AKTXN/A

CNSYN/A

Forward P/E (NTM)

AKTXN/A

CNSYN/A

Forward P/S (NTM)

AKTXN/A

CNSY1.12x

Revenue (TTM)

AKTX$0

CNSY$4M

Revenue Growth (YoY)

AKTXN/A

CNSYN/A

Forward Rev Growth

AKTX137.9%

CNSY216.6%

Gross Margin (TTM)

AKTX0.0%

CNSY0.0%

Operating Margin (TTM)

AKTX0.0%

CNSY0.0%

EBITDA Margin (TTM)

AKTX0.0%

CNSY-612.0%

Net Margin (TTM)

AKTX0.0%

CNSY-620.7%

FCF Margin (TTM)

AKTXN/A

CNSY-845.3%

Net Income (TTM)

AKTX$-31M

CNSY$-26M

FCF (TTM)

AKTX$-11M

CNSY$-36M

EPS (TTM)

AKTX-$0.40

CNSY-$3.78

ROE (TTM)

AKTX-14745.0%

CNSY-39417.0%

ROA (TTM)

AKTX-7470.0%

CNSY-15136.0%

ROIC (TTM)

AKTX-14027.0%

CNSY-37414.0%

Cash

AKTX$8M

CNSY$2M

Debt

AKTX$693K

CNSY$0

Net Cash/Debt

AKTX$7M

CNSY$2M

Current Ratio (TTM)

AKTX0.60x

CNSY1.37x

Quick Ratio (TTM)

AKTX0.56x

CNSY1.26x

Debt/Equity (TTM)

AKTX0.04x

CNSY0.19x

Debt/Assets (TTM)

AKTX0.0%

CNSY0.0%

Interest Coverage (TTM)

AKTXN/A

CNSYN/A

Net Debt/EBITDA (TTM)

AKTX0.00x

CNSY0.00x

Beta

AKTX1.48

CNSY2.21

52W Performance

AKTX-78.5%

CNSY-45.2%

YTD Performance

AKTX-24.4%

CNSY-45.2%

% from 52W High

AKTX-79.5%

CNSY-53.6%

% from 52W Low

AKTX190.4%

CNSY30.0%

Asset Turnover (TTM)

AKTX0.00x

CNSY0.24x

FCF Yield (TTM)

AKTX-63.0%

CNSY-267.6%

Earnings Yield (TTM)

AKTX-181.3%

CNSY-196.5%

Dividend Yield (TTM)

AKTXN/A

CNSYN/A

Rule of 40

AKTX0.0

CNSY-845.3

EV/GP/RG

AKTXN/A

CNSYN/A

Ticker research

View AKTX research View CNSY research

Metric	AKTX Akari Therapeutics PLC	CNSY Plus Therapeutics Inc
Market & Valuation
Market Cap	$17M	$13M
Enterprise Value	$10M	$11M
Price	$8.77	$1.93
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3.16x
EV/Sales	0.00x	2.60x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.83x	2.22x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.94x	-0.31x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	1.12x
Revenue & Growth
Revenue (TTM)	$0	$4M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	137.9%	216.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-612.0%
Net Margin (TTM)	0.0%	-620.7%
FCF Margin (TTM)	N/A	-845.3%
Net Income (TTM)	$-31M	$-26M
FCF (TTM)	$-11M	$-36M
EPS (TTM)	-$0.40	-$3.78
ROE (TTM)	-14745.0%	-39417.0%
ROA (TTM)	-7470.0%	-15136.0%
ROIC (TTM)	-14027.0%	-37414.0%
Financial Health
Cash	$8M	$2M
Debt	$693K	$0
Net Cash/Debt	$7M	$2M
Current Ratio (TTM)	0.60x	1.37x
Quick Ratio (TTM)	0.56x	1.26x
Debt/Equity (TTM)	0.04x	0.19x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.48	2.21
52W Performance	-78.5%	-45.2%
YTD Performance	-24.4%	-45.2%
% from 52W High	-79.5%	-53.6%
% from 52W Low	190.4%	30.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.24x
FCF Yield (TTM)	-63.0%	-267.6%
Earnings Yield (TTM)	-181.3%	-196.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-845.3
EV/GP/RG	N/A	N/A
Ticker research	View AKTX research	View CNSY research